Literature DB >> 321690

Inhibition of polymorphonuclear leukocyte capping by a chemotactic factor.

B F Mandell, I Spilberg, J Lichtman.   

Abstract

Incubation of human polymorphonuclear leukocytes with colchicine and fluorescein-concanavalin A leads to the formation of a polarized cap of fluorescence not seen if cells are incubated with fluorescein-Con A along. When cells are preincubated with a chemotactic factor before colchicine treatment, the capping is inhibited in a dose-related manner. Studies with alpha-methylmannoside indicate that the caps represent extracellular fluorescein-Con A and are not areas of Con A internalization. Experiments utilizing an irreversible inhibitor of serine esterases suggest that a chemotactic factor-activated enzyme is involved in the inhibition of cap formation in the human neutrophil.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 321690

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Demonstration of calcium-dependent chemotactic factor activatable esterase activity in human neutrophils: relationship with chemotaxis and chemotactic deactivation.

Authors:  J Mehta; B Mandell; T Kleyman; I Spilberg
Journal:  Inflammation       Date:  1981-06       Impact factor: 4.092

2.  Stimulus interactions in release of superoxide anion (O2-) from human neutrophils. Further evidence for multiple pathways of activation.

Authors:  J G Bender; D E Van Epps
Journal:  Inflammation       Date:  1985-03       Impact factor: 4.092

3.  Organophosphorus inhibition of lysosomal enzyme secretion from polymorphonuclear leucocytes. Evidence of a lack of a requirement for esterase activation.

Authors:  E L Becker; E P Koza; M Sigman
Journal:  Immunology       Date:  1978-08       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.